Moretta Gaia - IDI - Istituto Dermopatico dell'Immacolata

Dr.

Gaia

Moretta

Ruolo in Idi

Dirigente Medico

Ambulatorio

Dermatologia clinica correttiva e del benessere

Dermatologia clinica, Dermatologia clinica correttiva e del benessere

Degenza

Specializzazione

Dermatologia e Venereologia

Localizzazione

Attività di Servizio Sanitario Nazionale

Si

Attività di Ambulatorio Privato

Si

Lingue parlate

Inglese

Contatti

Expertise clinica

Psoriasi ed artrite psoriasica
Dermatite atopica
Acne
Epiluminescenza e controllo nevi
Dermatologia pediatrica
Dermato-oncologia (Melanoma,carcinoma basocellulare, cheratosi attiniche)
Laserterapia, Crioterapia e dermochirurgia
Peeling e medicina estetica

Biografia

Laurea in Medicina e Chirurgia presso l’Università Cattolica del Sacro Cuore di Roma con lode nel 2013
Specializzazione in Dermatologia e Venereologia con lode presso l’Università Cattolica del Sacro Cuore, Fondazione Policlinico A. Gemelli IRCCS nel 2018
Fellowship presso il dipartimento di Dermatologia pediatrica dell’Ospedale Pediatrico Bambino Gesù nel 2018
Master di II livello in Laser ed altre sorgenti di Luce presso l’Università degli studi di Roma Tor Vergata nel 2020

Formazione

Fellowship presso Ospedale pediatrico Bambino Gesù nel 2018
Master di II livello in Laser e Sorgenti di Luce nel 2020
Dermatology Academy di Medicina estetica, Modena 27-28 settembre 2021

Attività didattica e scientifica

Docente presso Master di Dermatologia clinica avanza ( Consorzio Universitario Humanitas)
Partecipazione come investigator a trial clinici nazionali ed internazionali (GULLIVER, BRIGHT, CANOVA, SUPREME, PsOsim, MK3222-P011)
Autrice di numerose pubblicazioni su riviste nazionali ed internazionali indicizzate (n° 23)

Pubblicazioni

2024 Jul 1 - Dermatology practical & conceptual - Effectiveness of Ixekizumab in Elderly Patients for the Treatment of Moderate-to-Severe Psoriasis: Results From a Multicenter, Retrospective Real-Life Study in the Lazio Region.

2024 Jul 24 - Clinical and experimental dermatology - Early Intervention and Cumulative Life Course Impairment in psoriasis: a Review.

2024 Aug - Italian journal of dermatology and venereology - The role of guselkumab in psoriatic artrithis and disease progression in patients with confirmed diagnosis of enthesitis.

2024 Apr 1 - Dermatology practical & conceptual - Long-Term Effectiveness of Brodalumab for the Treatment of Moderate-To-Severe Psoriasis: A Real-Life Multicenter Study of Up to 3 Years in a Real-Life Italian Cohort.

2023 Dec - The Journal of dermatological treatment - Analysis of predictive factors influencing dupilumab continuation rate in adult patients with atopic dermatitis: results from an Italian multicenter study.

2023 - Drugs in context - Effectiveness of risankizumab in the treatment of palmoplantar psoriasis: a 52-week Italian real-life experience.

2022 Sep 14 - Dermatology reports - Attitudes among dermatologists regarding actinic keratosis treatment options.

2022 Nov - Dermatologic therapy - Cutaneous Rosai-Dorfman disease after Covid 19 vaccination treated with thalidomide.

2022 Dec - Expert opinion on biological therapy - Real-world outcomes in patients with moderate-to-severe plaque psoriasis treated with guselkumab for up to 1 year.

2022 Jun - Dermatologic therapy - Risankizumab for the treatment of moderate-to-severe psoriasis: A multicenter, retrospective, 1 year real-life study.

2022 Jun - Dermatologic therapy - Tildrakizumab in moderate-to-severe plaque psoriasis: A multicenter, retrospective, real-life study.

2022 Feb 28 - International journal of molecular sciences - Multiple Roles for Cytokines in Atopic Dermatitis: From Pathogenic Mediators to Endotype-Specific Biomarkers to Therapeutic Targets.

2021 Sep 7 - Discover oncology - Attitudes among dermatologists regarding non-melanoma skin cancer treatment options.

2021 Aug 1 - Dermatology reports - Generalized acquired cutis laxa and urticarial dermatosis associated with k-chain IgA micromolecular myeloma.

2021 Sep - Expert opinion on biological therapy - Predictive factors of lack of response to adalimumab among bio-naive patients suffering from moderate-to severe psoriasis: analysis of a multicenter data collection in Italy.

2021 Jun 23 - Biomedicines - Merkel Cell Carcinoma.

2021 Jul - Dermatologic therapy - Efficacy of sonidegib for basal cell carcinoma in a patient affected by multiple infectious diseases.

2020 May - Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG - Erythema multiforme in a 14-year-old girl with Henoch-Schönlein purpura and pancolitis: a relationship with mesalazine?

2020 May - Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG - Erythema multiforme bei einem 14-jährigen Mädchen mit Purpura Schönlein-Henoch und Pankolitis: Ein Zusammenhang mit Mesalazin?

2019 Nov - Dermatologic therapy - Adalimumab in severe plaque psoriasis of childhood: A multi-center, retrospective real-life study up to 52 weeks observation.

2019 - Therapeutic advances in chronic disease - PsA-Disk, a novel visual instrument to evaluate psoriatic arthritis in psoriatic patients: an Italian derma-rheuma multicentre study.

2019 Jun - Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia - Moderate-to-severe psoriasis and pregnancy: impact on fertility, pregnancy outcome and treatment perspectives.

2019 Apr 1 - European journal of dermatology : EJD - Prevalence of cutaneous comorbidities in psoriatic patients and their impact on quality of life.

2019 May - Dermatologic therapy - Multiple paradoxical reactions during ixekizumab therapy.

2020 Oct - Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia - A case of chronic disseminated lupus erythematosus in a psoriatic patient receiving ustekinumab.

2018 Jul - Expert opinion on biological therapy - Secukinumab in moderate-to-severe plaque psoriasis: a multi-center, retrospective, real-life study up to 52 weeks observation.

2017 Dec 1 - Journal of dermatological case reports - Epstein-Barr virus-related cutaneous necrotizing vasculitis in a girl heterozygous for factor V Leiden.

2017 - Clinical, cosmetic and investigational dermatology - Management of refractory pityriasis rubra pilaris: challenges and solutions.

2017 Oct - European journal of pediatrics - Treatment of severe psoriasis in children: recommendations of an Italian expert group.

2017 Dec - International journal of dermatology - Linagliptin-induced bullous pemphigoid.

2018 Oct - Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia - A strange perianal ulcer.

2017 Aug 1 - European journal of dermatology : EJD - Linear IgA bullous dermatosis in a two-year-old child: possible association with aspirin.

2016 Sep - Pharmacogenetics and genomics - HLA-Cw6 allele, NFkB1 and NFkBIA polymorphisms play no role in predicting response to etanercept in psoriatic patients.

2014 Nov - Drug development research - A possible role of polycystic ovary syndrome for pregnancy complications in women with psoriasis.

Riconoscimenti

Premio per il miglior poster al congresso AIDNID 2018
Premio per il miglior Poster al X congresso internazionale ADIPSO 2018
Vincitrice del premio ELI Lilly Grant per il 26th EADV congress

Associazioni professionali

SiDeMast
ADOI
EADV

Numeri utili:

CUP

Assicurazione e Attività Privata

Numeri utili: CUP06 6646 4094,

Assicurazione e Attività Privata 06 6646 4499

© Fondazione Luigi Maria Monti – Sede Legale: Via Monti di Creta 104, 00167 Roma – PEC: fondazioneluigimariamonti@legalmail.it – CF 97831400581 – PI 13326621003
Informative e Privacy – Gestisci Cookie – Social media policy – Limitazione di responsabilità

Sito aggiornato al 19/09/2024 ore 08:48

SHORT LINK

La ricerca in IDI è finanziata da:

I NOSTRI SOCIAL

© Fondazione Luigi Maria Monti – Sede Legale: Via Monti di Creta 104, 00167 Roma – PEC: fondazioneluigimariamonti@legalmail.it – CF 97831400581 – PI 13326621003
Informative e Privacy – Gestisci Cookie – Social media policy – Limitazione di responsabilità

Sito aggiornato al 19/09/2024 ore 08:48

Powered by

Powered by